Last reviewed · How we verify

NCT06923748

Comparison of Two Interdental Devices for Peri-Implant Plaque Control

Completed NA Last updated 24 November 2025
What this trial tests

NA trial testing Superfloss in Peri-implant Mucositis in 52 participants. Completed in 6 November 2025.

Timeline
3 April 2025
Primary endpoint
6 November 2025
6 November 2025

Quick facts

Lead sponsorUniversity of Siena
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment52
Start date3 April 2025
Primary completion6 November 2025
Estimated completion6 November 2025
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

University of Siena

Who can join

Adults 18 to 80, any sex, with Peri-implant Mucositis or Peri-Implantitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This randomized clinical trial aims to compare the efficacy of two interproximal cleaning devices-superfloss and interdental brushes- in patients diagnosed with peri-implant diseases. The study evaluates plaque control and bleeding scores. Patients will be randomly assigned to one of two oral hygiene protocols and will be monitored through clinical examinations and validated questionnaires assessing both clinical and radiographic parameters and patient-reported outcomes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Superfloss

Trials testing the same drug.

Other recruiting trials for Peri-implant Mucositis

Currently open trials in the same condition.

Other University of Siena trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06923748.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing